Sonodynamic
therapy (SDT) is emerging as a non-invasive strategy to eradicate
tumors, but its therapeutic efficacy is still not ideal. To achieve more effective SDT, water insoluble sonosensitizer meso-5, 10, 15, 20-tetra(4-hydroxylphenyl)porphyrin (
THPP) is here esterified with
succinic acid conjugated
oxaliplatin prodrug (Oxa(IV)SA2) and carboxyl group terminated PEG (PEG5k-COOH). The obtained covalent organic
polymer (COP) of
THPP-Oxa(IV)-PEG with good physiological stability, sonosensitization efficacy and
glutathione (GSH) responsive oxalipatin responsive behaviors can induce effective immunogenic
cancer cell death upon the ultrasound exposure. In addition,
THPP-Oxa(IV)-PEG is shown to be a versatile carrier for both hydrophobic near infrared
dye and
radioisotope 99mTc, thereby enabling real-time tracking of its pharmacokinetics behavior under corresponding imaging facilities. Furthermore, treatment with
THPP-Oxa(IV)-PEG injection and ultrasound exposure is shown to be most effectively in suppressing
tumor growth, with 3 of 6 CT26
tumor bearing mice fully cured, ascribing to its high potency in eliciting profound antitumor immune responses. This work highlights a promising strategy in constructing multifunctional nanosonosensitizer as a potent immunogenic nanomedicine to enhance the treatment outcome of SDT.